Myelodysplastic syndromes

 

Myelodysplastic syndromes (MDS) are a diverse group of diseases that are characterised by an ‘inefficient’ bone marrow. The bone marrow makes insufficient numbers of blood cells, or blood cells that look very abnormal under the microscope and often do not function properly. This disorder can affect red blood cells, white blood cells, platelets or any combination of these cells. Sometimes myelodysplastic syndromes can cause too many immature blood cells to be produced in the bone marrow, which increases the possibility of these diseases turning into acute leukaemia. Myelodysplastic syndromes can range from very mild disorders which are simply monitored, through to symptomatic disorders requiring supportive care with red blood cell or platelet transfusions, and medications to prevent or treat infections. Some myelodysplastic syndromes are best treated with medications to reduce the risk of transformation into acute leukaemia.

Myelodysplastic syndromes can range from very mild disorders which are simply monitored, through to symptomatic disorders requiring supportive care with red blood cell or platelet transfusions, and medications to prevent or treat infections. Some myelodysplastic syndromes are best treated with medications to reduce the risk of transformation into acute leukaemia.

For All Appointments

Ph: (03) 9500 9345

Email: info@thebloodunit.com.au

Fax: (03) 9508 6014

 Argus